Login
Home
Charts
Search
Watchlist
Products

Thrive Future Habitats Limited

THRIVE·BSE
87.00-0.53%Tue, 22 Sept '26

Thrive Future Habitats Limited

THRIVE
BSE
87.00
-0.53%
|Tue, 22 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
98Cr
Close
Close Price
87.00
Industry
Industry
Personal Care
PE
Price To Earnings
PS
Price To Sales
77.54
Revenue
Revenue
1Cr
Rev Gr TTM
Revenue Growth TTM
-29.83%
PAT Gr TTM
PAT Growth TTM
52.68%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
111101100000
Growth YoY
Revenue Growth YoY%
-50.7-59.4-68.6-79.4-85.2-45.7-19.5-55.268.2-87.3-28.816.7
Expenses
ExpensesCr
222101111012
Operating Profit
Operating ProfitCr
-10-10000000-1-1
OPM
OPM%
-45.0-39.7-139.0-25.4-68.2-6.3-24.2-80.0-100.0-250.0-200.0-380.0
Other Income
Other IncomeCr
-814000-300101
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
-903000-3001-1-1
Tax
TaxCr
001000000000
PAT
PATCr
-902000-3000-1-1
Growth YoY
PAT Growth YoY%
-517.094.1168.897.498.5-28.6-249.0-600.0-200.0288.977.0-228.6
NPM
NPM%
-633.6-12.1241.5-6.0-63.6-28.6-447.0-93.3-113.5425.0-144.7-262.9
EPS
EPS
-20.2-0.34.3-0.1-0.3-0.4-6.3-0.3-0.40.4-0.8-0.8
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
111101100000
Growth YoY
Revenue Growth YoY%
-50.7-59.4-68.6-79.4-85.2-45.7-19.5-55.268.2-87.3-28.816.7
Expenses
ExpensesCr
222101111012
Operating Profit
Operating ProfitCr
-10-10000000-1-1
OPM
OPM%
-45.0-39.7-139.0-25.4-68.2-6.3-24.2-80.0-100.0-250.0-200.0-380.0
Other Income
Other IncomeCr
-814000-300101
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
-903000-3001-1-1
Tax
TaxCr
001000000000
PAT
PATCr
-902000-3000-1-1
Growth YoY
PAT Growth YoY%
-517.094.1168.897.498.5-28.6-249.0-600.0-200.0288.977.0-228.6
NPM
NPM%
-633.6-12.1241.5-6.0-63.6-28.6-447.0-93.3-113.5425.0-144.7-262.9
EPS
EPS
-20.2-0.34.3-0.1-0.3-0.4-6.3-0.3-0.40.4-0.8-0.8

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
6777101913127211
Growth
Revenue Growth%
15.4-1.710.735.695.9-30.5-9.4-44.7-67.6-43.8-29.8
Expenses
ExpensesCr
78791320202110334
Operating Profit
Operating ProfitCr
-1-1-1-1-3-1-6-9-40-2-3
OPM
OPM%
-17.1-20.1-12.1-17.6-31.5-5.6-47.5-70.4-55.5-21.9-142.4-223.6
Other Income
Other IncomeCr
020014005-212
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000011100
PBT
PBTCr
-11-1-1-33-7-9-3-3-1-2
Tax
TaxCr
000001001000
PAT
PATCr
-10-1-1-32-7-9-4-3-1-2
Growth
PAT Growth%
131.5-449.0-40.7-109.4152.4-563.7-31.455.921.169.552.7
NPM
NPM%
-15.24.2-14.7-18.7-28.97.7-51.6-74.8-59.8-145.6-78.8-132.3
EPS
EPS
-3.10.8-5.6-4.6-8.93.2-14.8-19.5-8.6-6.8-1.1-1.6
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
6777101913127211
Growth
Revenue Growth%
15.4-1.710.735.695.9-30.5-9.4-44.7-67.6-43.8-29.8
Expenses
ExpensesCr
78791320202110334
Operating Profit
Operating ProfitCr
-1-1-1-1-3-1-6-9-40-2-3
OPM
OPM%
-17.1-20.1-12.1-17.6-31.5-5.6-47.5-70.4-55.5-21.9-142.4-223.6
Other Income
Other IncomeCr
020014005-212
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000011100
PBT
PBTCr
-11-1-1-33-7-9-3-3-1-2
Tax
TaxCr
000001001000
PAT
PATCr
-10-1-1-32-7-9-4-3-1-2
Growth
PAT Growth%
131.5-449.0-40.7-109.4152.4-563.7-31.455.921.169.552.7
NPM
NPM%
-15.24.2-14.7-18.7-28.97.7-51.6-74.8-59.8-145.6-78.8-132.3
EPS
EPS
-3.10.8-5.6-4.6-8.93.2-14.8-19.5-8.6-6.8-1.1-1.6

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
333445555511
Reserves
ReservesCr
03124916116434
Current Liabilities
Current LiabilitiesCr
4423118610311
Non Current Liabilities
Non Current LiabilitiesCr
00110011000
Total Liabilities
Total LiabilitiesCr
61069171924198447
Current Assets
Current AssetsCr
334491014104143
Non Current Assets
Non Current AssetsCr
3635891010434
Total Assets
Total AssetsCr
61069171924198447
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
333445555511
Reserves
ReservesCr
03124916116434
Current Liabilities
Current LiabilitiesCr
4423118610311
Non Current Liabilities
Non Current LiabilitiesCr
00110011000
Total Liabilities
Total LiabilitiesCr
61069171924198447
Current Assets
Current AssetsCr
334491014104143
Non Current Assets
Non Current AssetsCr
3635891010434
Total Assets
Total AssetsCr
61069171924198447

Cash Flow

Consolidated
Standalone
Financial YearMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
9-4-1-4-7-9-710-3
Investing Cash Flow
Investing Cash FlowCr
-34-334-1000-18
Financing Cash Flow
Financing Cash FlowCr
003131300044
Net Cash Flow
Net Cash FlowCr
600103-61022
Free Cash Flow
Free Cash FlowCr
50-2-4-6-10-710-4
CFO To PAT
CFO To PAT%
3,400.1363.441.2128.9-471.9127.774.2-21.7-5.5347.9
CFO To EBITDA
CFO To EBITDA%
-701.4441.643.8118.3650.6138.678.9-23.4-36.2192.6
Financial YearMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
9-4-1-4-7-9-710-3
Investing Cash Flow
Investing Cash FlowCr
-34-334-1000-18
Financing Cash Flow
Financing Cash FlowCr
003131300044
Net Cash Flow
Net Cash FlowCr
600103-61022
Free Cash Flow
Free Cash FlowCr
50-2-4-6-10-710-4
CFO To PAT
CFO To PAT%
3,400.1363.441.2128.9-471.9127.774.2-21.7-5.5347.9
CFO To EBITDA
CFO To EBITDA%
-701.4441.643.8118.3650.6138.678.9-23.4-36.2192.6

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
3611131340352215319698
Price To Earnings
Price To Earnings
20.127.0
Price To Sales
Price To Sales
0.60.81.71.81.32.12.61.82.214.477.777.5
Price To Book
Price To Book
1.41.03.02.31.63.01.71.51.43.52.52.2
EV To EBITDA
EV To EBITDA
-5.2-3.8-13.5-9.6-3.8-36.3-4.7-2.6-4.0-67.1-42.2-29.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
23.928.515.110.516.628.419.612.2-12.817.019.119.1
OPM
OPM%
-17.1-20.1-12.1-17.6-31.5-5.6-47.5-70.4-55.5-21.9-142.4-223.6
NPM
NPM%
-15.24.2-14.7-18.7-28.97.7-51.6-74.8-59.8-145.6-78.8-132.3
ROCE
ROCE%
-22.015.5-19.9-23.7-34.021.0-31.3-58.5-27.4-31.9-1.9-1.9
ROE
ROE%
-37.15.1-25.5-24.8-36.411.1-33.4-59.8-36.4-35.0-2.1-2.1
ROA
ROA%
-14.32.9-15.5-15.6-16.87.8-28.9-47.7-49.6-86.5-2.1-2.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
3611131340352215319698
Price To Earnings
Price To Earnings
20.127.0
Price To Sales
Price To Sales
0.60.81.71.81.32.12.61.82.214.477.777.5
Price To Book
Price To Book
1.41.03.02.31.63.01.71.51.43.52.52.2
EV To EBITDA
EV To EBITDA
-5.2-3.8-13.5-9.6-3.8-36.3-4.7-2.6-4.0-67.1-42.2-29.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
23.928.515.110.516.628.419.612.2-12.817.019.119.1
OPM
OPM%
-17.1-20.1-12.1-17.6-31.5-5.6-47.5-70.4-55.5-21.9-142.4-223.6
NPM
NPM%
-15.24.2-14.7-18.7-28.97.7-51.6-74.8-59.8-145.6-78.8-132.3
ROCE
ROCE%
-22.015.5-19.9-23.7-34.021.0-31.3-58.5-27.4-31.9-1.9-1.9
ROE
ROE%
-37.15.1-25.5-24.8-36.411.1-33.4-59.8-36.4-35.0-2.1-2.1
ROA
ROA%
-14.32.9-15.5-15.6-16.87.8-28.9-47.7-49.6-86.5-2.1-2.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Thrive Future Habitats Limited is a contract manufacturer that makes the lotions, shampoos, and sanitizers you see on store shelves - but for other companies, not under its own name. Born from a personal-care division founded in 1986 within the 115-year-old Ador Group, the company spent decades as a behind-the-scenes production partner for household brands like Unilever and Himalaya. In early 2025, a new owner took control with plans to add a real estate division, but the factory in Puducherry - and the simple idea of making products for brands that need them - remains the engine that runs the business today. # Business segments Two engines at different stages - a contract-manufacturing mainstay that does the heavy lifting, and a clean-beauty platform that has been wound down to near zero. ## 1. Contract manufacturing: the factory behind the brands **The company runs a single, licensed factory in Puducherry that turns formulations into finished bottles, tubes, and bulk containers for everyone from large FMCG houses to small digital-first startups.** - **One-stop shop for brands** - it handles product development, raw-material sourcing, testing, manufacturing, packaging, warehousing, and even just-in-time inventory management, so a brand can hand over a concept and receive finished goods ready to sell. - **A library of 5,000 ready formulas** - built over more than 25 years of formulation work across skincare, haircare, and bath & body categories, this digital catalogue lets young brands pick a starting point instead of developing a product from scratch. - **Flexible batch sizes** - the factory has equipment for both small and large runs, with packaging that spans 5 ml bottles up to 50-litre drums, and it sets low minimum order quantities specifically to attract emerging brands that cannot meet the volume thresholds of larger manufacturers. - **Licensed for liquids, creams, and powders** - it holds cosmetic, Ayush, and pharmaceutical manufacturing licences, plus an alcohol licence with expandable sanction, which gave it one of India's largest alcohol-based sanitizer capacities during the pandemic surge. - **A tight crew and a focused footprint** - the company streamlined operations into one Puducherry facility with higher productivity, and as of March 2025 it employed just seven permanent people, keeping the operation lean. ## 2. Own brands and the Sublime Life platform: a clean-beauty experiment on pause **Through a subsidiary called 1908 E-Ventures, the company built a digital marketplace for clean skincare and a small portfolio of its own brands - then scaled it down sharply when cash ran low, leaving the subsidiary with zero turnover as of March 2025.** - **A curated clean-beauty marketplace** - the platform, Sublime Life, listed more than 160 international and homegrown brands (including Martiderm from Spain and Juicy Chemistry from India) and served over 100,000 customers with an average order value of roughly ₹1,250. - **Vertically integrated from the start** - because the parent company already had the Puducherry factory, 1908 could offer partner brands manufacturing, formulation, supply-chain management, and marketing alongside retail distribution on the platform. - **Acquisitions to fill the shelf** - 1908 bought the D2C home-cleaning brand Santic in late 2020 and the skin-and-hair-care brand Coccoon in early 2022, adding ready-made product lines to its own stable. - **Shuttered when losses mounted** - in July 2023 the subsidiary's board resolved to cut headcount, marketing, and technology spending because of a precarious cash position; by FY24 the parent had impaired its entire investment, and the subsidiary reported turnover of zero for the year ending March 2025. # Group structure and partners **A change of control in March 2025 brought in a new promoter group with a real estate mandate, while the company moved to clean up its legacy subsidiaries.** - **Old house, new owners** - the company was historically part of the Ador Group, with J B Advani and Company Private Limited as the promoter; in March 2025, Thrive Future Habitats Infra Private Limited and individuals led by Arvinder Singh Pasricha bought a 35.47% stake from the outgoing promoters and launched a mandatory open offer, ending with a 72.49% combined holding. - **A real estate pivot in the charter** - the company amended its object clause to add real estate business, is seeking shareholder approval to change its name to Thrive Future Habitats Limited, and plans to shift its registered office from Mumbai to New Delhi. - **Subsidiary clean-up underway** - as of March 2025 the company held 52.75% of 1908 E-Ventures and 58% of Aura Flow (formerly Anatomicals Ador India); it sold the Aura Flow stake in March 2026 for a nominal sum and is in the process of buying out the remaining shareholders of 1908 E-Ventures to make it a wholly owned subsidiary by end-2026. - **Joint ventures that faded** - a men's grooming venture with cricketer Ravi Shastri (23 Yards India) and a bath-and-body joint venture with Anatomicals UK were both launched with fanfare but generated negligible activity; the Anatomicals JV had zero turnover by FY25.

Documents — Thrive Future Habitats Limited

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/bveb2xdtewbg9hp884v4segt.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/ws26jr6mhsqc4mx35jjab43d.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/bafnh2q98trae4irdirf8d21.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/1p0uhh8upsgadkvx6h8vj689.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/qbgam0kaf2q7be8cdofiwsjo.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/iqc62v7aiorx4m0ad423eqkq.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/m7kx74er963qt724yoqu6c2i.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/7i0bawa1orih3jsf6zp20n1a.pdf
  • Q3 FY2023 Investor Presentation (Dec 2022, PDF): https://www.stockscans.in/document/l4draqz5b4m2yq803hrfeo7n.pdf
  • Q1 FY2023 Investor Presentation (Jun 2022, PDF): https://www.stockscans.in/document/krkiclb07r20mdwesvqjuvlc.pdf
  • Q4 FY2022 Investor Presentation (Mar 2022, PDF): https://www.stockscans.in/document/wnoqvcc7mwfitedqxp8dektk.pdf
  • Q3 FY2022 Investor Presentation (Dec 2021, PDF): https://www.stockscans.in/document/p8nsxeuo2j2fja9loi1dh3x2.pdf
  • Q1 FY2022 Investor Presentation (Jun 2021, PDF): https://www.stockscans.in/document/km90vggfxxaqzq1455mg1z98.pdf
  • Q1 FY2021 Investor Presentation (Jun 2020, PDF): https://www.stockscans.in/document/uqhw5qwq6mgtsr7kthcrr74k.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/lvtfjyve319o7k0y26jo7koo.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/uezd9i3yb3afumwuxw3p462f.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/8vcjxdom65civfq42xiryf3s.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/i9shyselhso82ocriyff7ciz.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/xymvfkon24tipfb0oozrfl7c.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/e3qbjcucjs843hfroqf7v77h.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/7gsm1obvhkjv3gvhbfe3t7u0.pdf